US Patent Issued to CHIA TAI TIANQING PHARMACEUTICAL GROUP on July 7 for "Sulfoximine-containing ATR inhibitor compound" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,948, issued on July 7, was assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP Co. LTD. (Lianyungang, China).

"Sulfoximine-containing ATR inhibitor compound" was invented by Mnsheng Zhang (Nanjing City, China), Yan Zhu (Nanjing City, China), Baomin Liu (Nanjing City, China), Kuo Gai (Nanjing City, China), Shaowei Chen (Nanjing City, China) and Wei Shi (Nanjing City, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A sulfoximine-containing ATR inhibitor compound as represented by formula (I), a preparation method therefor, a pharmaceutical composition containing same, and the use thereof in the treatment of ATR-related or ATR-mediated diseases and/...